SCHEMBL22018240

SCHEMBL22018240

C=Cc1ncc(NC(=O)C2CC/C=C\CCCCC2)c(N2CCCCC2)c1SCC

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.36
TSHR P16473 2/20 0.36
NPC1 O15118 1/20 0.36
KMT2A Q03164 2/20 0.34
HDAC3 O15379 1/20 0.34
HDAC1 Q13547 1/20 0.34
HDAC2 Q92769 1/20 0.34
MEN1 O00255 1/20 0.34
PTPN11 Q06124 1/20 0.33
ABL1 P00519 1/20 0.32
GLA P06280 1/20 0.32
SMN1; SMN2 Q16637 3/20 0.32
THRB P10828 1/20 0.32
ALDH1A1 P00352 1/20 0.32
HPGD P15428 1/20 0.32
HSD17B10 Q99714 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
CETP P11597 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19059705 0.94 TSHR (0.40) MAPK1TSHRNPC1KMT2AHDAC3
SCHEMBL20368738 0.94 TSHR (0.40) MAPK1TSHRNPC1KMT2AHDAC3
SCHEMBL18399595 0.94 TSHR (0.40) MAPK1TSHRNPC1KMT2AHDAC3
SCHEMBL22018173 0.85 MAPK1 (0.37) MAPK1TSHRKMT2AHDAC3HDAC1
SCHEMBL21157778 0.82 HDAC3 (0.40) MAPK1TSHRKMT2AHDAC3HDAC1
SCHEMBL22853571 0.79 ABL1 (0.34) MAPK1TSHRKMT2AHDAC3HDAC1
SCHEMBL18399528 0.78 MAPK1 (0.41) MAPK1TSHRKMT2AHDAC3HDAC1
SCHEMBL22018416 0.76 MAPK1 (0.39) MAPK1TSHRKMT2AMEN1ABL1
SCHEMBL22018233 0.75 MAPK1 (0.38) MAPK1TSHRKMT2AMEN1ABL1
SCHEMBL22018242 0.75 SMN1; SMN2 (0.39) MAPK1TSHRNPC1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10828290-B2 Thiazolecarboxamides and pyridinecarboxamide compounds useful as pim kinase inhibitors INCYTE CORPORATION (US) 2020-11-10 US disclosed
US-20200155527-A1 THIAZOLECARBOXAMIDES AND PYRIDINECARBOXAMIDE COMPOUNDS USEFUL AS PIM KINASE INHIBITORS INCYTE HOLDINGS CORPORATION 2020-05-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200155527-A1 THIAZOLECARBOXAMIDES AND PYRIDINECARBOXAMIDE COMPOUNDS USEFUL AS PIM KINASE INHIBITORS PIM2, PIM1, PIM3 MAPK1 263/4885TSHR 1947/4885NPC1 2615/4885
US-10828290-B2 Thiazolecarboxamides and pyridinecarboxamide compounds useful as pim kinase inhibitors PIM2, PIM1, PIM3 MAPK1 263/4885TSHR 1947/4885NPC1 2615/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.